499 related articles for article (PubMed ID: 19617833)
1. Bleeding and venous thromboembolism in the critically ill with emphasis on patients with renal insufficiency.
Cook DJ; Douketis J; Arnold D; Crowther MA
Curr Opin Pulm Med; 2009 Sep; 15(5):455-62. PubMed ID: 19617833
[TBL] [Abstract][Full Text] [Related]
2. Preventing venous thromboembolism in critically ill patients.
Crowther MA; Cook DJ
Semin Thromb Hemost; 2008 Jul; 34(5):469-74. PubMed ID: 18956287
[TBL] [Abstract][Full Text] [Related]
3. Venous thromboembolism in critical illness in a community intensive care unit.
Muscedere JG; Heyland DK; Cook D
J Crit Care; 2007 Dec; 22(4):285-9. PubMed ID: 18086398
[TBL] [Abstract][Full Text] [Related]
4. Thromboprophylaxis in the intensive care unit: focus on medical-surgical patients.
Cook DJ; Crowther MA
Crit Care Med; 2010 Feb; 38(2 Suppl):S76-82. PubMed ID: 20083918
[TBL] [Abstract][Full Text] [Related]
5. Prophylaxis against venous thromboembolism in neurointensive care patients: survey of Canadian practice.
Scales DC; Riva-Cambrin J; Le TL; Pinto R; Cook DJ; Granton JT;
J Crit Care; 2009 Jun; 24(2):176-84. PubMed ID: 19501306
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcome of patients with venous thromboembolism and renal insufficiency. Findings from the RIETE registry.
Falgá C; Capdevila JA; Soler S; Rabuñal R; Sánchez Muñoz-Torrero JF; Gallego P; Monreal M;
Thromb Haemost; 2007 Oct; 98(4):771-6. PubMed ID: 17938800
[TBL] [Abstract][Full Text] [Related]
7. Thromboprophylaxis in medical-surgical critically ill patients.
Crowther MA; Cook DJ
Curr Opin Crit Care; 2008 Oct; 14(5):520-3. PubMed ID: 18787443
[TBL] [Abstract][Full Text] [Related]
8. Deep vein thrombosis prophylaxis: friend or foe.
Rahman S
Am J Ther; 2009; 16(4):300-3. PubMed ID: 19092638
[TBL] [Abstract][Full Text] [Related]
9. Venous thromboembolism in medical critically ill patients: prevalence and incidence.
Adimi Naghan P; Malekmohammad M; Jamaati H; Sharifkashani B; Najafi A; Hashemian SM
Acta Med Iran; 2013 Apr; 51(3):168-71. PubMed ID: 23605601
[TBL] [Abstract][Full Text] [Related]
10. Thromboprophylaxis in acutely ill medical patients: results of a survey among Italian physicians.
Dentali F; Pomero F; La Regina M; Orlandini F; Turato S; Mazzone A; Nozzoli C; Fontanella A; Ageno W; Agnelli G; Campanini M
Thromb Res; 2014 Sep; 134(3):572-7. PubMed ID: 24997800
[TBL] [Abstract][Full Text] [Related]
11. Dalteparin thromboprophylaxis for critically ill medical-surgical patients with renal insufficiency.
Rabbat CG; Cook DJ; Crowther MA; McDonald E; Clarke F; Meade MO; Lee KA; Cook RJ
J Crit Care; 2005 Dec; 20(4):357-63. PubMed ID: 16310608
[TBL] [Abstract][Full Text] [Related]
12. Venous thromboembolism and bleeding in critically ill patients with severe renal insufficiency receiving dalteparin thromboprophylaxis: prevalence, incidence and risk factors.
Cook D; Douketis J; Meade M; Guyatt G; Zytaruk N; Granton J; Skrobik Y; Albert M; Fowler R; Hebert P; Pagliarello G; Friedrich J; Freitag A; Karachi T; Rabbat C; Heels-Ansdell D; Geerts W; Crowther M;
Crit Care; 2008; 12(2):R32. PubMed ID: 18315876
[TBL] [Abstract][Full Text] [Related]
13. Venous thromboembolism prophylaxis in critically ill patients.
McLeod AG; Geerts W
Crit Care Clin; 2011 Oct; 27(4):765-80, v. PubMed ID: 22082513
[TBL] [Abstract][Full Text] [Related]
14. Prevention of venous thromboembolism in hospitalized medical patients: addressing some practical questions.
Douketis JD
Curr Opin Pulm Med; 2008 Sep; 14(5):381-8. PubMed ID: 18664966
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of thrombotic risk factors: the difficulty in using clinical trials to develop a risk assessment model.
Laporte S; Mismetti P
Crit Care Med; 2010 Feb; 38(2 Suppl):S10-7. PubMed ID: 20083908
[TBL] [Abstract][Full Text] [Related]
16. Safety of dalteparin for the prophylaxis of venous thromboembolism in elderly medical patients with renal insufficiency: a pilot study.
Tincani E; Mannucci C; Casolari B; Turrini F; Crowther MA; Prisco D; Cenci AM; Bondi M
Haematologica; 2006 Jul; 91(7):976-9. PubMed ID: 16757417
[TBL] [Abstract][Full Text] [Related]
17. Complications from vascular disrupting agents and angiogenesis inhibitors: aberrant control of hemostasis and thrombosis.
van Heeckeren WJ; Sanborn SL; Narayan A; Cooney MM; McCrae KR; Schmaier AH; Remick SC
Curr Opin Hematol; 2007 Sep; 14(5):468-80. PubMed ID: 17934353
[TBL] [Abstract][Full Text] [Related]
18. Determining the safety of enoxaparin prophylaxis in critically ill patients with severe renal insufficiency - The PACER pilot study.
Castellucci LA; Shaw J; Giulivi A; Edwards C; Carrier M; Patel R
Thromb Res; 2016 Aug; 144():69-71. PubMed ID: 27294776
[No Abstract] [Full Text] [Related]
19. Prophylaxis against deep vein thrombosis in critically ill patients with severe renal insufficiency with the low-molecular-weight heparin dalteparin: an assessment of safety and pharmacodynamics: the DIRECT study.
Douketis J; Cook D; Meade M; Guyatt G; Geerts W; Skrobik Y; Albert M; Granton J; Hébert P; Pagliarello G; Marshall J; Fowler R; Freitag A; Rabbat C; Anderson D; Zytaruk N; Heels-Ansdell D; Crowther M;
Arch Intern Med; 2008 Sep; 168(16):1805-12. PubMed ID: 18779469
[TBL] [Abstract][Full Text] [Related]
20. Hemostasis and thrombosis in critically ill children.
Kenet G; Strauss T; Kaplinsky C; Paret G
Semin Thromb Hemost; 2008 Jul; 34(5):451-8. PubMed ID: 18956285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
